We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-6.21%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$599M
AUM Growth
+$74.7M
Cap. Flow
+$118M
Cap. Flow %
19.64%
Top 10 Hldgs %
40.16%
Holding
178
New
72
Increased
28
Reduced
20
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 33.02%
2 Healthcare 13.64%
3 Industrials 6.17%
4 Consumer Staples 4.64%
5 Energy 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBT icon
1
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
$66.6M 11.11%
3,250,000
+1,250,000
+63% +$24M
CTLP
2
DELISTED
Cantaloupe
CTLP
$35.2M 5.88%
5,206,500
+198,500
+4% +$1.51M
STKL
3
DELISTED
SunOpta
STKL
$27.8M 4.65%
5,305,000
+1,238,900
+30% +$6.53M
STAA icon
4
STAAR Surgical
STAA
$1.13B
$20.9M 3.49%
+261,450
New +$19.5M
MBII
5
DELISTED
Marrone Bio Innovations, Inc.
MBII
$19.8M 3.3%
18,335,767
TBT icon
6
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
$17M 2.83%
828,500
+725,500
+704% +$13.9M
SGRY icon
7
Surgery Partners
SGRY
$2.04B
$15.4M 2.57%
280,000
-60,000
-18% -$2.97M
EVA
8
DELISTED
Enviva Inc.
EVA
$13.1M 2.18%
+165,000
New +$12M
FTAI icon
9
CALL
FTAI Aviation
FTAI
$21.8B
$12.7M 2.13%
579,645
-117,100
-17% -$2.6M
TWLO icon
10
Twilio
TWLO
$29.5B
$12.2M 2.03%
74,000
+64,500
+679% +$11.8M
XBI icon
11
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$12.1M 2.02%
135,000
+45,000
+50% +$4.16M
AZN icon
12
AstraZeneca
AZN
$267B
$12M 2%
90,500
+90,175
+27,746% +$10.8M
S icon
13
SentinelOne
S
$6.29B
$10.9M 1.81%
280,500
+93,000
+50% +$3.8M
AMPS
14
DELISTED
Altus Power
AMPS
$10.3M 1.72%
1,385,000
-17,500
-1% -$137K
AMBA icon
15
Ambarella
AMBA
$3.03B
$10.1M 1.68%
96,000
+87,000
+967% +$11.1M
DT icon
16
Dynatrace
DT
$12.7B
$9.98M 1.67%
212,000
-124,000
-37% -$5.84M
VST icon
17
Vistra
VST
$50.1B
$9.94M 1.66%
427,500
-175,000
-29% -$3.88M
SEDG icon
18
SolarEdge
SEDG
$2.44B
$9.67M 1.61%
30,000
+15,000
+100% +$4.12M
HLIT icon
19
Harmonic Inc
HLIT
$1.2B
$9.21M 1.54%
991,750
-51,250
-5% -$502K
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8.94M 1.49%
85,000
-55,000
-39% -$5.36M
EOG icon
21
EOG Resources
EOG
$74.4B
$8.94M 1.49%
75,000
-1,000
-1% -$111K
FIVN icon
22
FIVE9
FIVN
$2.08B
$8.93M 1.49%
+80,850
New +$9.41M
COUP
23
DELISTED
Coupa Software Incorporated
COUP
$8.64M 1.44%
85,000
+24,650
+41% +$2.98M
THC icon
24
Tenet Healthcare
THC
$22.6B
$8.6M 1.43%
100,000
-30,000
-23% -$2.46M
ALT icon
25
Altimmune
ALT
$581M
$8.24M 1.37%
1,353,000
+299,000
+28% +$2.2M

Similar funds

Ardsley Advisory Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Ardsley Advisory Partners held 178 positions worth $599M, up 14% from $525M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ardsley Advisory Partners deployed $118M of net new capital in Q1 2022, opening 72 new positions and adding to 28 existing holdings. Its largest new stake was STAAR Surgical: 261,450 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 38% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was FerroAtlántica, an estimated $9.1M trimmed.

  • Ardsley Advisory Partners's largest Q1 2022 buy was STAAR Surgical: 261,450 shares worth $20.9M.
  • Ardsley Advisory Partners added most to ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2022, an estimated $13.9M increase.
  • Ardsley Advisory Partners's biggest Q1 2022 reduction was FerroAtlántica, cutting an estimated $9.1M.
  • Ardsley Advisory Partners fully exited Global Payments in Q1 2022, selling an estimated $7.71M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $599M portfolio in Q1 2022.
  • Ardsley Advisory Partners opened 72 new positions and closed 52 in Q1 2022.
  • Ardsley Advisory Partners's portfolio value rose 14% quarter-over-quarter to $599M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2022, filed 16 May 2022.